Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 28.0B | 25.9B | 45.8B | 38.6B |
Cost of revenue | 24.8B | 23.2B | 37.5B | 34.6B |
Gross profit | 3.1B | 2.7B | 8.3B | 4.1B |
Operating expense | ||||
Research & development | 888.3M | 821.1M | 798.7M | 739.0M |
Selling general and admin | 1.8B | 1.8B | 1.9B | 1.6B |
Other operating expenses | — | — | — | — |
Operating income | 425.5M | 104.5M | 5.7B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 343.4M | 52.3M | 6.4B | 1.4B |
Tax provision | 89.6M | 14.9M | 1.9B | 425.5M |
Net income | 253.8M | 37.3M | 4.5B | 948.0M |
Basic EPS | 0.0 | 0 | — | 0.1 |
Diluted EPS | 0.0 | 0 | — | 0.1 |
Basic average shares | 8.0B | 7.5B | — | 7.3B |
Diluted average shares | 8.0B | 7.5B | — | 7.3B |
EBITDA | 425.5M | 59.7M | 6.4B | 1.8B |
Net income from continuing op. | 253.8M | 37.3M | 4.5B | 948.0M |
Minority interests | -14.9M | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |